4D Path Collaborates with AMD and Oracle to Accelerate Predictive Oncology
Written by Emily J. Thompson, Senior Investment Analyst
Source: Globenewswire
Updated: 22 hour ago0mins
- Collaborative Innovation: 4D Path's partnership with AMD and Oracle aims to accelerate clinical trials and enhance tumor prediction efficiency and accuracy by utilizing AMD EPYC™ CPUs on Oracle Cloud Infrastructure, thereby advancing personalized cancer treatment.
- Technological Breakthrough: The QPOR™ platform from 4D Path can rapidly convert routine biopsy images into interpretable biomarkers of tumor and immune response, significantly reducing costs and improving reproducibility to meet high clinical trial standards.
- Clinical Application: QPOR has been validated in blinded retrospective studies and is currently part of ongoing prospective clinical trials, demonstrating its readiness for real-world oncology applications and advancing personalized cancer care.
- Market Potential: By providing explainable and regulatory-friendly insights, the collaboration between 4D Path, AMD, and Oracle not only accelerates clinical trial execution but also offers patients more personalized treatment options, presenting a vast market opportunity.
AMD.O
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
No Data
Powered By
Intellectia
Analyst Views on AMD
Wall Street analysts forecast AMD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMD is 281.78 USD with a low forecast of 200.00 USD and a high forecast of 350.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
37 Analyst Rating
27 Buy
10 Hold
0 Sell
Moderate Buy
Current: 221.620
Low
200.00
Averages
281.78
High
350.00
Current: 221.620
Low
200.00
Averages
281.78
High
350.00
Raymond James
Outperform
initiated
$377
2025-11-20
Reason
Raymond James
Price Target
$377
2025-11-20
initiated
Outperform
Reason
Raymond James assumed coverage of AMD (AMD) with an Outperform rating and $377 price target. The firm believes AMD is best positioned to compete with Nvidia (NVDA) in the merchant graphics processing unit market. The firm sees continued momentum for the company in accelerators and artificial intelligence rack systems "despite investor skepticism."
Mizuho
Outperform
maintain
$275 -> $285
2025-11-12
Reason
Mizuho
Price Target
$275 -> $285
2025-11-12
maintain
Outperform
Reason
Mizuho raised the firm's price target on AMD to $285 from $275 and keeps an Outperform rating on the shares following the analyst day. The company sees sales growing at 35% annually, which implies 2026 and 2027 revenue inline with estimates but 2028 through 2030 sales above expectatoins, the analyst tells investors in a research note. Mizuho upped numbers following AMD's laying out of longer term financial targets.
Goldman Sachs
James Schneider
Neutral
maintain
$210
2025-11-12
Reason
Goldman Sachs
James Schneider
Price Target
$210
2025-11-12
maintain
Neutral
Reason
AMD's 2025 Financial Analyst Day highlighted strong long-term targets above market expectations, supported by anticipated Datacenter growth in AI GPUs and CPUs, Goldman Sachs analyst James Schneider tells investors in a research note. While progress in Datacenter GPUs and CPUs remains solid, the firm keeps a Neutral rating and $210 price target on the shares given reliance on the OpenAI deal and execution uncertainty.
BofA
Buy
maintain
$300
2025-11-12
Reason
BofA
Price Target
$300
2025-11-12
maintain
Buy
Reason
After having attended AMD's analyst day event, BofA notes rack-scale execution, operating expense prudence, and the lack of an effective networking portfolio remain risks, but argues that AMD's "strong" AI roadmap and annual product/rack cadence could help it reach its 10%-pluse AI share target in "one of the fastest growing end markets in semis history." The firm maintains its Buy rating and $300 price target on AMD shares.
See All Ratings
About AMD
Advanced Micro Devices, Inc. is a global semiconductor company. The Company is focused on high-performance computing, graphics and visualization technologies. Its segments include Data Center, Client and Gaming, and Embedded. Data Center segment includes artificial intelligence (AI) accelerators, microprocessors (CPUs) for servers, graphics processing units (GPUs), accelerated processing units (APUs), data processing units (DPUs), Field Programmable Gate Arrays (FPGAs), smart network interface Cards (SmartNICs) and Adaptive system-on-Chip (SoC) products for data centers. Client and Gaming segment includes CPUs, APUs, chipsets for desktops and notebooks, discrete GPUs, and semi-custom SoC products and development services. Embedded segment includes embedded CPUs, GPUs, APUs, FPGAs, system on modules (SOMs), and Adaptive SoC products. It markets and sells its products under the AMD trademark. Its products include AMD EPYC, AMD Ryzen, AMD Ryzen PRO, Virtex UltraScale+, and others.
About the author
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sigh Up to Get Intellectia Insights
How does Nvidia's AI server achieve a 10x performance boost?
What factors contribute to AMD's stock being considered a top choice?
Will AMD's collaboration with HPE strengthen its position in AI infrastructure?
Can Nvidia maintain its market dominance amid competition from AMD and Google?